Cardiac support and replacement systems;Kardiale Unterstützungs- und Ersatzsysteme

Medizinische Klinik - Intensivmedizin und Notfallmedizin

Volumn 112, Issue 5, 2017, Pages 417-425

  Graf, T ^a,b   Thiele, H ^a,b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Cardiogenic shock; Extracorporeal membrane oxygenation; Hypothermia; Myocardial infarction; Myocardial revascularization

Indexed keywords

CATECHOLAMINE;

ACCIDENTAL HYPOTHERMIA; ACUTE CORONARY SYNDROME; ARTIFICIAL VENTILATION; CARDIAC SUPPORT AND REPLACEMENT SYSTEM; CARDIOGENIC SHOCK; EXTRA CORPOREAL LIFE SUPPORT; EXTRACORPOREAL CIRCULATION; HEART ARREST; HEART FUNCTION; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MORTALITY; MYOCARDITIS; RESUSCITATION; REVASCULARIZATION; REVIEW; EXTRACORPOREAL OXYGENATION; HEART ASSIST DEVICE; TREATMENT OUTCOME;

EXTRACORPOREAL MEMBRANE OXYGENATION; HEART ARREST; HEART-ASSIST DEVICES; HUMANS; SHOCK, CARDIOGENIC; TREATMENT OUTCOME;

EID: 85018380927     PISSN: 21936218     EISSN: 21936226     Source Type: Journal    
DOI: 10.1007/s00063-017-0295-8     Document Type: Review

References (48)

1. Goldberg RJ, Spencer FA, Gore JM et al (2009) Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation 119:1211–1219
2. Thiele H, Schuler G (2009) Cardiogenic shock: to pump or not to pump? Eur Heart J 30:389–390
3. Werdan K, Buerke M, Engelmann L et al (2011) Deutsch-Österreichische S3-Leitlinie Infarktbedingter kardiogener Schock. Diagnose, Monitoring und Therapie. Kardiologe 5:166–224
4. Kern MJ, Aguirre F, Bach R et al (1993) Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty. Circulation 87:500–511
5. Prondzinsky R, Unverzagt S, Russ M et al (2013) Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial. Shock 37:378–384
6. den Uil CA, Lagrand WK, van der Ent M et al (2009) The effects of intra-aortic balloon pump support on macrocirculation and tissue microcirculation in patients with cardiogenic shock. Cardiology 114:42–46
7. den Uil CA, Lagrand WK, van der Ent M et al (2010) Impaired microcirculation predicts poor outcome of patients with acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 31:3032–3039
8. Jung C, Lauten A, Ferrari M (2010) Microcirculation in cardiogenic shock: from scientific bystander to therapy target. Crit Care 14:193
9. Sjauw KD, Engstrom AE, Vis MM et al (2009) A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 30:459–468
10. Altayyar S, Rochwerg B, Alnasser S et al (2014) Intra-aortic balloon pump in patients with cardiogenic shock complicating myocardial infarction: a systematic review and meta-analysis of randomized trials. Syst Rev 3:24
11. Prondzinsky R, Lemm H, Swyter M et al (2010) Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med 38:152–160
12. O’Gara PT, Kushner FG, Ascheim DD et al (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 127:529–555
13. Bengtson JR, Kaplan AJ, Pieper KS et al (1992) Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. J Am Coll Cardiol 20:1482–1489
14. Thiele H, Schuler G, Neumann FJ et al (2012) Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Am Heart J 163:938–945
15. Thiele H, Zeymer U, Neumann FJ et al (2012) Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367:1287–1296
16. Thiele H, Zeymer U, Neumann FJ et al (2013) Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 382:1638–1645
17. Kolh P, Windecker S, Alfonso F et al (2014) 2014 ESC/EACTS Guidelines on myocardial revascularizationTask Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg 46:517–592
18. Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 14:2129–2200
19. Roffi M, Patrono C, Collet JP et al (2015) 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 37:267–315
20. Sandhu A, McCoy L, Smita IN et al (2015) Use of mechanical circulatory support in patients undergoing percutaneous coronary intervention insights from the National Cardiovascular Data Registry. Circulation 132:1243–1251
21. Stretch R, Sauer CM, Yuh DD et al (2014) National trends in the utilization of short-term mechanical circulatory support. J Am Coll Cardiol 14:1407–1415
22. Takayama H, Truby L, Koekort M et al (2013) Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era. J Heart Lung Transplant 32:106–111
23. Combes A, Leprince P, Luyt CE (2008) Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med 36:1404–1411
24. Cheng R, Hachamovitch R, Kittleson M et al (2014) Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients. Ann Thorac Surg 97:610–616
25. Pappalardo F, Schulte C, Pieri M et al (2016) Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. Eur J Heart Fail. doi:10.1002/ejhf.668
26. Weymann A, Schmack B, Sabashnikow S et al (2014) Central extracorporeal life support with left ventricular decompression for the treatment of refractory cardiogenic shock and lung failure. J Cardiothorac Surg 29:9–60
27. Cheng R, Hachamovitch R, Makkar R et al (2015) Lack of survival benefit found with use of intraaortic balloon pump in extracorporeal membrane oxygenation. J Invasive Cardiol 27:453–458
28. Ouweneel DM, Eriksen E, Sjauw KD et al (2017) Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol 69:278–287
29. Zeymer U, Thiele H (2017) Mechanical support for cardiogenic shock: lost in translation? J Am Coll Cardiol 69:288–290
30. Beurtheret S, Mordant P, Paoletti X et al (2013) Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program). Eur Heart J 34:112–120
31. de Waha S, Graf T, Desch S et al (2017) Outcome of elderly undergoing extracorporeal life support in refractory cardiogenic shock. Clin Res Cardiol. doi:10.1007/s00392-016-1068-8
32. Chen YS, Lin JW, Yu HY et al (2008) Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis. Lancet 372:554–561
33. Ouweneel D, Schotborgh JV, Limpens J et al (2016) Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis. Int Care Med 42:1922–1934
34. Burkhoff D, Cohen H, Brunckhorst C et al (2006) A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 152(469):e1–e8
35. Thiele H, Sick P, Boudriot E et al (2005) Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 26:1276–1283
36. Weil BR, Konecny F, Suzuki G et al (2016) Comparative Hemodynamic effects of contemporary percutaneous mechanical circulatory support devices in a porcine model of acute myocardial infarction. JACC Cardiovasc Interv 9:2292–2303
37. Arrigoni SC, Kuijpers M, Mecozzi G (2011) Use of a novel short-term mechanical circulatory support device for cardiac recovery. Interact Cardiovasc Thorac Surg 12:891–894
38. Engstrom AE, Cocchieri R, Driessen AH et al (2011) The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: The Academic Medical Center intensive care unit experience. Crit Care Med 39:2072–2079
39. Lamarche Y, Cheung A, Ignaszewski A et al (2011) Comparative outcomes in cardiogenic shock patients managed with Impella microaxial pump or extracorporeal life support. J Thorac Cardiovasc Surg 42:60–65
40. Anastasiadis K, Chalvatzoulis O, Antonitsis P et al (2011) Left ventricular decompression during peripheral extracorporeal membrane oxygenation support with the use of the novel iVAC pulsatile paracorporeal assist device. Ann Thorac Surg 92:2257–2259
41. Cheng JM, den Uil CA, Hoeks SE et al (2009) Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J 30:2102–2108
42. Marty P, Roquilly A, Vallee F et al (2013) Lactate clearance for death prediction in severe sepsis or septic shock patients during the first 24 h in intensive care unit: an observational study. Ann Intensive Care 3:3
43. Nguyen HB, Rivers EP, Knoblich BP et al (2004) Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 32:1637–1642
44. Attana P, Lazzeri C, Chiostri M et al (2012) Lactate clearance in cardiogenic shock following ST elevation myocardial infarction: a pilot study. Acute Card Care 14:20–26
45. Lamarche Y, Cheung A, Ignaszewski A et al (2011) Comparative outcomes in cardiogenic shock patients managed with Impella microaxial pump or extracorporeal life support. J Thorac Cardiovasc Surg 142:60–65
46. Brown DJ, Brugger H, Boyd J et al (2012) Accidental hypothermia. N Engl J Med 367:1930–1938
47. Monsieurs KG, Nolan JP, Bossaert LL et al (2015) European Resuscitation Council Guidelines for Resuscitation. Resuscitation 95:1–312
48. Thiele H et al (2015) Management of cardiogenic shock. Eur Heart J 36:1223–1230